SERA Sera Prognostics, Inc.
2.050USD+2.50%Mkt Cap: 80.87M $P/E: —2d ago
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM t…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap80.87M USD
Enterprise Value37.43M USD
Revenue (TTM)70.00K USD
Gross Profit-83.00K USD
Net Income (TTM)-31.93M USD
Revenue/Share0.0010 USD
Last Price2.050 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees71
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.83
PEG—
EV/EBITDA-1.02
EV/Revenue534.68
P/S1155.31
P/B1.36
EPS (TTM)-0.67
EPS (Forward)-0.54
52W Range
1.56021% of range3.950
52W High3.950 USD
52W Low1.560 USD
Profitability
Gross Margin-102.47%
Oper. Margin-33346.67%
EBITDA Margin0.00%
Profit Margin-39417.28%
ROE-42.34%
ROA-31.32%
Growth
Revenue Growth76.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.62M USD
CapEx (TTM)726.00K USD
FCF Margin-26985.18%
FCF Yield-23.36%
Net Debt-43.44M USD
Net Debt/EBITDA1.19
Balance Sheet
Debt/Equity0.03
Current Ratio1.98
Quick Ratio1.91
Book Value/Sh1.51 USD
Cash/Share1.18 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.500 USD
Upside (mean)+168.3%
Target Range5.000 USD – 6.000 USD
5.000+168.3% to mean6.000
# Analysts2
Ownership
Shares Out.38.48M
Float27.71M
Insiders12.13%
Institutions50.20%
Short Interest
Short Ratio8.6d
Short % Float0.68%
Short % Out.0.54%
Shares Short213.89K
Short (prev mo.)225.26K
Technical
SMA 502.044 (+0.3%)
SMA 2002.258 (-9.2%)
Beta1.06
S&P 52W Chg16.45%
Avg Vol (30d)21.60K
Avg Vol (10d)11.67K
Technical Indicators
RSI (14)50.4
MACD0.0028
MACD Signal0.0047
MACD Hist.-0.0018
BB Upper2.125 USD
BB Middle2.040 USD
BB Lower1.955 USD
BB Width8.32%
ATR (14)0.1015 USD
Vol Ratio (20d)0.19x